Study of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC)
Clinical trial NCT07670858 · RECRUITING
Trial details
- NCT number
- NCT07670858
- Sponsor
- Feldan Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-30
- Primary completion
- 2027-02-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.